Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rilonacept in Muckle-Wells and Schnitzler Syndrome
NCT01045772Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jan 2009
- Primary completion
- Sep 2010
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of rilonacept in Muckle-Wells syndrome (MWS), Schnitzler syndrome, sponsored by Charité – Universitätsmedizin Berlin. Started Jan 2009; status: completed.
02
Drugs
rilonacept
03
Conditions
Muckle-Wells syndrome (MWS)Schnitzler syndrome
Beyond the preview
Go deeper on NCT01045772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01045772.